Board

Prof. Radwa Mehanna

President

Prof. Radwa Mehanna

Radwa Ali Mehanna MD,PhD,DABRM

President of the Egyptian Society of Extracellular Vesicles (ESEV)
Professor of Medical Physiology, Faculty of Medicine, AlexandriaUniversity
Director of the Medical research Center, Faculty of Medicine, AlexandriaUniversity
Executive Manager of the Center of Excellence for Research in Regenerative Medicine and its Applications (CERRMA) in the faculty of Medicine alexandria University
Diplomate and Egyptian affiliate of the American Board of Regenerative Medicine

Orcid ID 0000-0001-9048-4464

Scopus ID 55851530300

Google Scholar, ResearchGate

Web of Science Researcher ID J-6885-2019

Biography

Dr. Radwa Ali Mehanna is a Professor of Medical Physiology at the Faculty of Medicine, Alexandria University, with over 20 years of extensive experience in the fields of stem cells and cell culture. She currently serves as the Director of the Medical research Center and the Executive Manager of the Center of Excellence for Research in Regenerative Medicine and its Applications (CERRMA) in the Faculty of Medicine, Alexandria University. She is the President and founder of the Egyptian Society of Extracellular Vesicles (ESEV). Dr. Mehanna is a Diplomate and the official Egyptian affiliate of the American Board of Regenerative Medicine (ABRM). She is also an associate editor for the Journal of Extracellular Vesicles (JEV) and a board member of the World Journal of Stem Cells.

Dr. Mehanna is an active member of several prominent international and local societies, including the International Society for Stem Cell Research (ISSCR), the International Society for Extracellular Vesicles (ISEV), the Tissue Engineering and Regenerative Medicine International Society (TERMIS), the Egyptian Association of Regenerative Medicine, Egyptian Society for Tissue Engineering and Regenerative Medicine, and the Egyptian Society of Medical Physiology.

She has made significant contributions to the field of regenerative medicine, particularly in stem cells and extracellular vesicles, publishing in reputable international journals and reviewing numerous peer-reviewed publications.

Dr. Mehanna also leads a dedicated research team of 25 scientists at CERRMA, who, under her leadership, have made impactful scientific advancements. Her groundbreaking research and leadership have earned her widespread recognition as a pioneer and thought leader in regenerative medicine, both nationally and internationally.

Dr. Eman Thabet

Vice President

Dr. Eman Thabet

Eman Helmy Thabet MD PhD

Vice president of the Egyptian Society of Extracellular Vesicles (ESEV)

Lecturer of Medical Physiology, Alexandria Faculty of Medicine, Alexandria, Egypt

Vice executive manager of the Centre of Excellence for Research in Regenerative Medicine & Research Applications (CERRMA), Alexandria Faculty of Medicine, Alexandria, Egypt.

Former Fulbright Scholar at Eli & Edythe Broad Center for Regeneration Medicine, University of California, San Francisco, USA.

Orchid ID 0000-0003-3490-3825

Google scholar

Biography

Dr. Eman M. Helmy Hassan Thabet, MD, PhD is a Lecturer of Medical Physiology at the Faculty of Medicine, Alexandria University, and a Postdoctoral Researcher and Vice Executive Manager at the Centre of Excellence for Research in Regenerative Medicine and its Applications (CERRMA). A Fulbright alumna and affiliate of the American Board of Regenerative Medicine, her research centers on stem cell biology, extracellular vesicles, and regenerative and personalized medicine, with a particular focus on cardiovascular, metabolic, and reproductive diseases. She has led and contributed to multiple nationally and internationally funded projects and completed predoctoral research at UCSF and postdoctoral research Harvard-affiliated institutions. Dr. Thabet is Vice President and Co-founder of the Egyptian Society of Extracellular Vesicles and an active member of several international scientific societies, with a strong commitment to translational research, scientific education, and laboratory policy implementation.

Dr. Dina Rostom

Secretary

Dr. Dina Rostom

Dr. Dina. M. Rostom, MD, PHD

Lecturer of Histology and cell biology at Faculty of Medicine, Alexandria University.

Dr Rostom is the Secretary of the Egyptian Society of Extracellular vesicles.

Dr. Rostom earned her PHD in the Field of Regenerative Medicine, specifically the role of extracellular vesicles on liver disease. Being one of the first Egyptian researchers to explore this topic Dr. Rostom has been really enthusiastic about the role of EVs in disease treatment.

Dr. Rostom enjoys transferring of knowledge, skills and experiences to fellow researchers and strongly believes that with expertise and purpose, EVs can be the solution to the world’s toughest health challenges.

Google Scholar

Orchid ID : 0000-0002-6200-2621

Dr. Samar El Achy

Treasurer

Dr. Samar El Achy

Samar El Achy MD PhD

Treasurer of the Egyptian Society of Extracellular Vesicles (ESEV)

Associate Professor of Anatomical Pathology, Alexandria Faculty of Medicine, Alexandria, Egypt

Executive manager of the Nanomedicine laboratory at the Centre of Excellence for Research in Regenerative Medicine & Research Applications (CERRMA), Alexandria Faculty of Medicine, Alexandria, Egypt.

Affiliate of the American Board for Regenerative Medicine (ABRM) in Egypt.

Former Research Scholar at Northwestern University Feinberg School of Medicine, Chicago, USA.

Orchid ID 0000-0002-0024-3585

Google Scholar

Biography

Dr. Samar Nabil El Achy, MD, PhD is an Associate Professor of Anatomical Pathology at the Faculty of Medicine, Alexandria University, and the Executive Manager of the Nanomedicine laboratory at the Centre of Excellence for Research in Regenerative Medicine and its Applications (CERRMA). Dr. El Achy first encountered nanoparticle research during her PhD at Northwestern University, USA, in nanomedicine in prostate cancer diagnosis and treatment. Dr. El Achy played a pivotal role in the establishment of a comprehensive research center for regenerative medicine, cell culture, and nanomedicine. Over the past 10 years, her research has focused on the use of nanotheranostics for cancer detection, treatment, and gene delivery nanotherapeutics. Currently, Dr El Achy focuses on employment of extracellular vesicles as biomarkers for cancer diagnosis in liquid biopsies. She has contributed to multiple nationally and internationally funded projects and completed predoctoral research at Northwestern Feinberg School of Medicine. Dr. EL Achy is currently the Treasurer of the Egyptian Society of Extracellular Vesicles and an active member of several international scientific societies, with a strong commitment to translational research, scientific education, and cancer diagnosis.

Dr. Raghda Saad Zaghloul Taleb

Board Member

Dr. Raghda Saad Zaghloul Taleb

Dr. Taleb is an assistant professor of Clinical and Chemical Pathology, Faculty of Medicine, Alexandria University, Egypt.

She holds an MD in Clinical and Chemical Pathology and completed part of her doctoral research at the Medical Proteome Center, Ruhr University Bochum, Germany, through a DAAD scholarship.

She currently serves as the Executive Manager of Proteomics Lab, and Vice-Executive Manager of Medical Research Center, Faculty of Medicine, Alexandria University, Egypt.

She is the Vice-President of Egyptian Proteomics Association (EgyPA) and active member of several national and international scientific societies.

Her research focuses on extracellular vesicles as cancer biomarkers using proteomics and genomics techniques.

Dr. Osama Saher

Board Member

Dr. Osama Saher

Osama Saher

ESEV Borad member and Director of Research and Scientific Affairs.

Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden

& Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt

Biography

Dr. Osama Saher is a pharmaceutical scientist and Assistant Professor with extensive experience in drug delivery, gene therapy, and molecular biotechnology. He is currently a postdoctoral researcher at the Department of Laboratory Medicine, Karolinska Institutet, Sweden, where his work focuses on the design and optimization of advanced delivery systems for oligonucleotide therapeutics, extracellular vesicles, and mRNA-based therapies. His research bridges pharmaceutical formulation science with molecular and cellular biology, with a strong emphasis on translational and regenerative medicine applications.

Dr. Saher received his PhD in Medical Science from Karolinska Institutet and holds master’s and bachelor’s degrees in Pharmaceutical Sciences from Cairo University. He has authored 23 peer-reviewed publications in high-impact journals, accumulating more than 650 citations and an H-index of 12 (Scopus). His work has been supported by multiple competitive grants from Karolinska Institutet and Swedish research foundations, including major postdoctoral and project funding.

In addition to his research activities, Dr. Saher has substantial teaching and supervision experience at both undergraduate and postgraduate levels in Sweden and Egypt. He is a frequent invited speaker and session chair at international conferences in oligonucleotide therapeutics, extracellular vesicles, and gene therapy, and is actively engaged in interdisciplinary collaboration and mentorship within the global biomedical research community.

Prof. Radwa Ali Mehanna

President

Dr. Eman Helmy Thabet

Vice President

Dr. Dina Rostom

Secretary

Dr. Samar El Achy

Treasurer